Lewis Williams

Lewis Williams

Directeur/Membre du Conseil chez PROTAGONIST THERAPEUTICS, INC.

Fortune : 510 743 $ au 31/05/2026

76 ans
Health Technology
Consumer Services
Technology Services

Profil

Lewis T.
Williams
was the founder of COR Therapeutics, Inc., founded in 1989, serving as Director from 1989 to 2007.
Dr. Williams was the founder of Five Prime Therapeutics, Inc., founded in 2001, serving as Director in 2019.
Dr. Williams is the founder of Walking Fish Therapeutics, Inc., founded in 2018, serving as Chairman & Chief Executive Officer since 2019.
Current jobs include Independent Director at Protagonist Therapeutics, Inc. since 2017, Member at the National Academy of Sciences, and Partner at Quan Capital Management LLC.
Former jobs include Director & Chief Scientific Officer at Chiron Corp.
from 1999 to 2001, Director at Beckman Coulter, Inc. from 2009 to 2011, Director-Cardiovascular & Daiichi Research at The University of California, San Francisco from 1993 to 2013, Independent Director at Arcellx, Inc. from 2019 to 2022, Independent Director at Neoleukin Therapeutics, Inc. from 2019 to 2022, and various director, president, chief scientific officer, chief technology officer, cardiologist, and principal roles at multiple organizations including Duke University, William Marsh Rice University, Berklee College of Music, Juvaris BioTherapeutics, Inc., Aquinox Pharmaceuticals, Inc., Cardiovascular Research Institute, Medsphere Systems Corp., The General Hospital Corp., Bridge Medical, Inc., AmerisourceBergen Technology Group, Novartis Vaccines & Diagnostics, Inc., Chiron Technologies, Inc., and Harvard Medical School.
Education includes a doctorate from Duke University and an undergraduate degree from William Marsh Rice University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
13/03/2026 5 130 ( 0,01 % ) 510 743 $ 31/05/2026

Postes actifs de Lewis Williams

SociétésPosteDébut
PROTAGONIST THERAPEUTICS, INC. Directeur/Membre du Conseil 08/06/2017
Directeur Général 01/02/2019
Corporate Officer/Principal -
Private Equity Investor -

Anciens postes connus de Lewis Williams

SociétésPosteFin
ARCELLX, INC. Directeur/Membre du Conseil 16/05/2022
NEUROGENE INC. Directeur/Membre du Conseil 02/03/2022
FIVE PRIME THERAPEUTICS, INC. Directeur Général 02/01/2018
Corporate Officer/Principal 01/08/2013
Directeur/Membre du Conseil 30/06/2011
Voir l'expérience en détail de Lewis Williams

Formation de Lewis Williams

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Consumer Services

Health Services

Technology Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Consumer Services

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Lewis Williams
🔇